首页> 外国专利> COMPOSITION AND METHOD FOR PREVENTING RESTENOSIS FOLLOWING REVASCULARIZATION PROCEDURE

COMPOSITION AND METHOD FOR PREVENTING RESTENOSIS FOLLOWING REVASCULARIZATION PROCEDURE

机译:分流术后预防再狭窄的组合物和方法

摘要

PPROBLEM TO BE SOLVED: To provide a method which reduces or prevents restenosis following invasiveness revascularization procedures, and to provide a composition therefor. PSOLUTION: The method for reducing or preventing the restenosis that occurs following the revascularization procedure, comprises administering to a mammal in need of such treatment a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and an active agent selected from a group consisting of, (a) a selective adenosine ASB2A/SBreceptor agonist, (b) the combination of a selective adenosine ASB1/SBantagonist and either a selective adenosine ASB2A/SBreceptor agonist or a non-selective adenosine agonist, and (c) a selective adenosine ASB1/SBantagonist in order to block the adenosine ASB1/SBreceptor activation by endogenously released adenosine. An surgical procedure is also improved relies on selective stimulation of adenosine ASB2A/SBreceptors. PCOPYRIGHT: (C)2009,JPO&INPIT
机译:<要解决的问题:提供一种减少或防止侵入性血运重建手术后的再狭窄的方法,并为此提供一种组合物。

解决方案:用于减少或预防在血运重建术之后发生的再狭窄的方法,包括向需要这种治疗的哺乳动物施用药物组合物,所述药物组合物包含药学上可接受的载体或稀释剂以及选自以下的活性剂: ,(a)选择性腺苷A 2A 受体激动剂,(b)选择性腺苷A 1 拮抗剂和选择性腺苷A 2A的组合受体激动剂或非选择性腺苷激动剂,以及(c)选择性腺苷A 1 拮抗剂,以通过内源性释放的腺苷来阻断腺苷A 1 受体活化。腺苷A 2A 受体的选择性刺激也改善了手术程序。

版权:(C)2009,日本特许厅&INPIT

著录项

  • 公开/公告号JP2009149668A

    专利类型

  • 公开/公告日2009-07-09

    原文格式PDF

  • 申请/专利权人 ADERIS PHARMACEUTICALS INC;

    申请/专利号JP20090034613

  • 发明设计人 MARTIN PAULINE L;MCAFEE DONALD A;

    申请日2009-02-17

  • 分类号A61K45;A61K31/7076;A61K31/52;A61K31/522;A61K31/437;A61K31/525;A61P9/10;A61P43;

  • 国家 JP

  • 入库时间 2022-08-21 19:42:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号